Patent Assignment
Reel/Frame 017087/0681
Corrective Assignment to Correct the Assignee Information Previously Recorded on Reel 016982 Frame 0383. Assignor(S) Hereby Confirms the Assignees Should Be Listed as: Astrazeneca Ab and Nps Pharmaceuticals, Inc..
Recorded: 2006-01-30
Pages: 14
Assignor
NPS PHARMACEUTICALS, INC.
Executed: 2005-12-07
Assignees
NPS PHARMACEUTICALS, INC.
383 COLOROW DRIVE, SALT LAKE CITY, UTAH, 84108
ASTRAZENECA AB
SE-151 85, SODERTALJE, SWEDEN
Covered Properties
(3)
Heteropolycyclic Compounds and Their Use as Metabotropic Glutamate Receptor Antagonists
Heteropolycyclic Compounds and Their Use as Metabotropic Glutamate Receptor Antagonists
mGluR antagonists
Application:
60/269,847 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 4, 2002
From: VAN WAGENEN, BRADFORD C.; STORMANN, THOMAS M.; MOE, SCOTT T.; SHEEHAN, SUSAN M.
To: NPS PHARMACEUTICALS, INC.
Reel/Frame 012758/0798 →
Assignment of Assignor's Interest
Jan 6, 2006
From: NPS PHARMACEUTICALS
To: ASTRAZENECA AB
Reel/Frame 016982/0383 →
Assignment of Assignor's Interest
Jan 6, 2006
From: VAN WAGENEN, BRADFORD; STORMANN, THOMAS M.; MOE, SCOTT T; SHEEHAN, SUSAN M
To: NPS PHARMACEUTICALS; ASTRAZENECA AB
Reel/Frame 016982/0393 →
Assignment of Assignor's Interest
Oct 25, 2007
From: NPS PHARMACEUTICALS, INC.; ASTRAZENECA AB
To: ASTRAZENECA AB
Reel/Frame 020045/0150 →